Fluconazole prophylaxis in the very low birth weight infant: Not ready for prime time

Pediatrics

Volumn 107, Issue 2, 2001, Pages 404-406

  Neely, Michael N ^a   Schreiber, John R ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

CANDIDA; CANDIDIASIS; DRUG EFFICACY; HOSPITAL INFECTION; HUMAN; INFANT; NOTE; PREMATURITY; PRIORITY JOURNAL; PROPHYLAXIS; TREATMENT OUTCOME; VERY LOW BIRTH WEIGHT;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; FLUCONAZOLE; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; RECTUM;

EID: 0035143953     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.107.2.404     Document Type: Note

References (21)

1. Nosocomial bloodstream infections in United States hospitals: A three-year analysis
2. Risk factors for candidemia in Neonatal Intensive Care Unit patients
3. Candidemia in a neonatal intensive care unit: Trends during fifteen years and clinical features of 111 cases
4. Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant
5. Gastrointestinal colonization with yeast species and Candida septicemia in very low birth weight infants
6. Fungal colonization in the very low birth weight infant
7. Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial
8. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation
9. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high- risk surgical patients
10. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation-a prospective, randomized, double-blind study
11. Association of fungal colonization and invasive disease in very low birth weight infants
12. Pharmacokinetics of oral fluconazole in premature infants
13. Treatment of candidal infections with fluconazole in neonates and infants
14. Clinical pharmacology of systemic antifungal agents: A comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development
15. Expression of CYP3A in the human liver - Evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth
16. Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life
17. Incidence of Candida parapsilosis colonization in an intensive care nursery population and its association with invasive fungal disease
18. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period
19. Candida fungemia in neonates treated with fluconazole: Report of forty cases, including eight with meningitis
20. The treatment of systemic candidiasis in neonates with oral fluconazole
21. Fluconazole vs amphotericin B for the treatment of neonatal fungal septicemia: A prospective randomized trial